Ledger.Open graph →
SEC Form D · filed October 19, 2015

4D Molecular Therapeutics Inc

Offering
$11.6M
Sold
$11.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
EMERYVILLE, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Theresa Janke · Emeryville, CAExecDavid Schaffer · Emeryville, CADirectorDavid Kirn · Emeryville, CAExec · DirectorChristopher L. O'Dell · New York, NYDirectorJeffrey H. Gelfand · New York, NYExecNoel C. Langlois · New York, NYExec · DirectorSharon Tetlow · Emeryville, CADirectorMargi Mcloughlin · South San Francisco, CADirectorLee L. Spector · New York, NYDirectorGiselle H. Lopez-Velasco · New York, NYExec · DirectorFrancie L. Tai · New York, NYExecSharon Tetlow · Emeryville, CADirectorMargi Mcloughlin · South San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗